|
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes
|
Jan 2017
|
Ther Adv Hematol
|
myelodysplastic syndromes (MDS)
|
|
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes
|
Jun 2016
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
|
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes.
|
Jan 2017
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
|
Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia
|
Jun 2015
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
May 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria
|
Mar 2014
|
J Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients
|
Jan 2016
|
Immunobiology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes
|
Nov 2014
|
Eur J Oncol Nurs
|
myelodysplastic syndromes (MDS)
|
|
Self-reported sleep disturbance and survival in myelodysplastic syndromes
|
Mar 2017
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
